Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 6/20 | 0.34 |
| ▸ | PPOX | P50336 | 6/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6280511 | 0.82 | BCAT1 (0.34) | ALDH1A1HPGD | |
| SCHEMBL7018779 | 0.82 | PDE4B (0.35) | ALDH1A1HPGDPPOXMEN1GAA | |
| SCHEMBL10579206 | 0.81 | BCAT1 (0.35) | ALDH1A1HPGDGRM4PPOXGAA | |
| SCHEMBL29195290 | 0.77 | PPOX (0.42) | ALDH1A1HPGDPPOXMEN1GAA | |
| SCHEMBL29195294 | 0.75 | LMNA (0.50) | ALDH1A1HPGDPPOXMEN1GAA | |
| SCHEMBL29195240 | 0.74 | PPOX (0.39) | PPOXGAAMAPT | |
| SCHEMBL7248396 | 0.74 | HSP90AA1 (0.33) | HPGDGRM4MEN1MAPTKMT2A | |
| SCHEMBL7254631 | 0.74 | PPOX (0.43) | ALDH1A1HPGDPPOXGAAMAPT | |
| SCHEMBL7254636 | 0.74 | PPOX (0.43) | ALDH1A1HPGDPPOXGAAMAPT | |
| SCHEMBL6281325 | 0.73 | ALDH1A1 (0.34) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6927193-B2 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2005-08-09 | — | — | US | disclosed |
| US-20040267014-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-1432692-A1 | ARYL ETHER DERIVATIVES AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-20030195118-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. | 2003-10-16 | — | — | US | disclosed |
| US-6613718-B2 | 2,3-Dihydro-2-thioxo-pyrimidinone derivatives | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2003-09-02 | — | — | US | disclosed |
| WO-2003029225-A1 | ARYL ETHER DERIVATIVES AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195118-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | CBR3, CBR1, DDT | ALDH1A1 906/4885HPGD 2705/4885GRM4 1928/4885 |
| US-20040267014-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | CBR3, HDHD5, DDT | ALDH1A1 943/4885HPGD 3003/4885GRM4 1534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.